Maximize Your Impact At Advanced Therapies UK 2026
Advanced Therapies UK 2026, taking place on March 17, 2026, at ExCeL London, brings together the global cell and gene therapy community to accelerate new treatment pathways and strategic collaborations. As one of the most influential events in the life sciences calendar, the conference draws senior executives from biopharma, biotech, and regulatory agencies who are actively shaping the future of advanced therapies.
Attendees include decision-makers leading evaluations of technology platforms, manufacturing capacity, and clinical partnerships across the sector. The event creates room for innovation-driven conversations and funding discussions that often lead to long-term partnerships. With access to Vendelux’s enriched attendee list, your team can identify which executives are attending, what types of organizations they represent, and how those align with your business strategy. Early engagement matters—the right outreach ahead of the event can set the tone for high-value meetings on-site.
How Sales, Marketing And Revops Teams Can Use This Attendee List
Biotech business development and commercial teams can leverage the Advanced Therapies UK 2026 attendee list to prioritize outreach efforts by identifying clinical-stage companies, strategic leads, or operations executives responsible for partnering decisions. Using enriched attendee data, your team can filter contacts based on therapeutic focus, organization size, or job function to target prospects with relevant solutions. Whether you’re offering clinical trial support, manufacturing capabilities, or enabling technologies for therapy development, aligning messaging to company priorities creates clear points of engagement.
Book meetings in advance with budget holders in translational research, business development, or regulatory affairs. Use this time to build relationships that extend beyond the conference booth. After the event, follow up by referencing key discussions or shared goals to foster continuity and partnership potential. The attendee list turns generalized outreach into specific, high-conversion engagement—helping your teams understand how to get more meetings with attendees who have the authority to act.
Timing Is Everything
Advanced Therapies UK 2026 will be held on March 17, 2026. With deal conversations and partnership evaluations beginning well in advance, early outreach is key to securing high-priority interactions.
Using Vendelux’s attendee insights, your team can begin pre-event engagement as early as Q4 2025. Upload your list of target accounts to identify confirmed or predicted attendees and align outreach accordingly. This allows time to set meetings, adapt messaging, and position your offering around each company’s upcoming strategic initiatives. Starting early helps solidify your presence before calendars fill up and allows for more meaningful interactions on-site.
What’s Included In The Advanced Therapies UK 2026 Attendee List?
Vendelux provides visibility into executives expected to attend Advanced Therapies UK 2026 using a combination of organizer-supplied information and predictive analysis. Clients can upload a list of target accounts to see matched attendees already confirmed or likely to participate.
The enriched attendee list includes first and last name, job title, company name, company website, location (city, state, country), LinkedIn profile, verified email address, and phone numbers where available.
Where Is Advanced Therapies UK 2026?
The event will be held at ExCeL London in London, England, United Kingdom.
When Is Advanced Therapies UK 2026?
Advanced Therapies UK 2026 is scheduled for March 17, 2026.
What Type Of Event Is Advanced Therapies UK 2026?
Advanced Therapies UK 2026 is a life sciences industry event focused on cell and gene therapy. It features keynote addresses, panel discussions, and one-on-one partnering meetings designed to support collaboration between therapy developers, investors, regulators, and service providers.
How Many People Attend Advanced Therapies UK 2026?
The event is expected to bring together more than 1,200 attendees from over 35 countries, including senior executives from biotech and pharma companies, investors, and policymakers involved in shaping the future of advanced therapies.
